[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.166.74.94. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
September 19, 2007

Malaria Chemoprophylaxis for Coalition Troops in Afghanistan—Reply

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2007;298(11):1275-1276. doi:10.1001/jama.298.11.1275-b

In Reply: Dr Tepper and colleagues point out that Canadian troops serving in Afghanistan are now offered alternatives to mefloquine for their malaria chemoprophylaxis in theater. Mefloquine has been associated with serious psychiatric events during travel abroad.1 A recent survey of case reports found that mefloquine has also been associated with 19 deaths in users, including 3 suicides.2 It is therefore reasonable to avoid prescribing a drug with potential serious risks (mefloquine) as first-line prophylaxis against an infection (P vivax malaria) that has low regional endemicity, seasonal transmission, and low lethality.

First Page Preview View Large
First page PDF preview
First page PDF preview
×